Cargando…

KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico

INTRODUCTION: Systemic Sclerosis (SSc) is an autoimmune, inflammatory, and multisystemic disease characterized by the presence of autoantibodies and fibrosis. The pathogenesis involves the interaction between immune system cells such as macrophages, NK cells, T cells, and B cells. Killer-cell Immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado-Sulbaran, Andrea Carolina, Ramírez-Dueñas, María Guadalupe, Navarro-Zarza, José Eduardo, Muñoz-Valle, José Francisco, Mendoza-Carrera, Francisco, Baños-Hernández, Christian Johana, Parra-Rojas, Isela, Montoya-Buelna, Margarita, Sánchez-Hernández, Pedro Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339729/
https://www.ncbi.nlm.nih.gov/pubmed/30723749
http://dx.doi.org/10.1155/2019/6808061
_version_ 1783388679049314304
author Machado-Sulbaran, Andrea Carolina
Ramírez-Dueñas, María Guadalupe
Navarro-Zarza, José Eduardo
Muñoz-Valle, José Francisco
Mendoza-Carrera, Francisco
Baños-Hernández, Christian Johana
Parra-Rojas, Isela
Montoya-Buelna, Margarita
Sánchez-Hernández, Pedro Ernesto
author_facet Machado-Sulbaran, Andrea Carolina
Ramírez-Dueñas, María Guadalupe
Navarro-Zarza, José Eduardo
Muñoz-Valle, José Francisco
Mendoza-Carrera, Francisco
Baños-Hernández, Christian Johana
Parra-Rojas, Isela
Montoya-Buelna, Margarita
Sánchez-Hernández, Pedro Ernesto
author_sort Machado-Sulbaran, Andrea Carolina
collection PubMed
description INTRODUCTION: Systemic Sclerosis (SSc) is an autoimmune, inflammatory, and multisystemic disease characterized by the presence of autoantibodies and fibrosis. The pathogenesis involves the interaction between immune system cells such as macrophages, NK cells, T cells, and B cells. Killer-cell Immunoglobulin-like Receptors (KIR) are expressed in NK cells and some T cell subsets that recognize HLA class I molecules as ligands and are involved in regulating the activation and inhibition of these cells. The KIR family consists of 14 genes and two pseudogenes; according to the gene content, the genotype could be AA and Bx. The aim of this study was to evaluate the association between KIR/HLA genes and genotypes with SSc and the clinical characteristics. METHODS: We included 50 SSc patients and 90 Control Subjects (CS). Genotyping of KIR, HLA-C, -Bw4, and -A(∗)03/(∗)11 was made by SSP-PCR. RESULTS: In SSc patients, a higher frequency of KIR2DL2 (p = 0.0007, p′ = 0.011), KIR2DS4del (p = 0.001, p′ = 0.021), and HLA-C2 (p = 0.02, p′ = 0.09) was found. This is the first study to evaluate the frequency of HLA-A(∗)03/(∗)11 in SSc patients, of which a low frequency was found in both groups. Compound genotypes KIR2DL2+/HLA-C1+ or KIR2DL2+/HLA-C2+ have a higher frequency in SSc patients. The Bx genotype was the most frequent and was associated with risk to SSc (p = 0.007, OR = 3.1, 95% CI = 1.4–7.9, p′ = 0.014). The genotypes with a higher iKIR number than aKIR (iKIR > aKIR) were found in all individuals; genotypes with 7-8 iKIR genes were increased in SSc patients. We do not find an association between the KIR genes with the clinical characteristics. CONCLUSION: The results suggest that KIR2DL2 and 2DS4del could have a risk role in the development of SSc, but not with clinical manifestations.
format Online
Article
Text
id pubmed-6339729
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63397292019-02-05 KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico Machado-Sulbaran, Andrea Carolina Ramírez-Dueñas, María Guadalupe Navarro-Zarza, José Eduardo Muñoz-Valle, José Francisco Mendoza-Carrera, Francisco Baños-Hernández, Christian Johana Parra-Rojas, Isela Montoya-Buelna, Margarita Sánchez-Hernández, Pedro Ernesto J Immunol Res Research Article INTRODUCTION: Systemic Sclerosis (SSc) is an autoimmune, inflammatory, and multisystemic disease characterized by the presence of autoantibodies and fibrosis. The pathogenesis involves the interaction between immune system cells such as macrophages, NK cells, T cells, and B cells. Killer-cell Immunoglobulin-like Receptors (KIR) are expressed in NK cells and some T cell subsets that recognize HLA class I molecules as ligands and are involved in regulating the activation and inhibition of these cells. The KIR family consists of 14 genes and two pseudogenes; according to the gene content, the genotype could be AA and Bx. The aim of this study was to evaluate the association between KIR/HLA genes and genotypes with SSc and the clinical characteristics. METHODS: We included 50 SSc patients and 90 Control Subjects (CS). Genotyping of KIR, HLA-C, -Bw4, and -A(∗)03/(∗)11 was made by SSP-PCR. RESULTS: In SSc patients, a higher frequency of KIR2DL2 (p = 0.0007, p′ = 0.011), KIR2DS4del (p = 0.001, p′ = 0.021), and HLA-C2 (p = 0.02, p′ = 0.09) was found. This is the first study to evaluate the frequency of HLA-A(∗)03/(∗)11 in SSc patients, of which a low frequency was found in both groups. Compound genotypes KIR2DL2+/HLA-C1+ or KIR2DL2+/HLA-C2+ have a higher frequency in SSc patients. The Bx genotype was the most frequent and was associated with risk to SSc (p = 0.007, OR = 3.1, 95% CI = 1.4–7.9, p′ = 0.014). The genotypes with a higher iKIR number than aKIR (iKIR > aKIR) were found in all individuals; genotypes with 7-8 iKIR genes were increased in SSc patients. We do not find an association between the KIR genes with the clinical characteristics. CONCLUSION: The results suggest that KIR2DL2 and 2DS4del could have a risk role in the development of SSc, but not with clinical manifestations. Hindawi 2019-01-06 /pmc/articles/PMC6339729/ /pubmed/30723749 http://dx.doi.org/10.1155/2019/6808061 Text en Copyright © 2019 Andrea Carolina Machado-Sulbaran et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Machado-Sulbaran, Andrea Carolina
Ramírez-Dueñas, María Guadalupe
Navarro-Zarza, José Eduardo
Muñoz-Valle, José Francisco
Mendoza-Carrera, Francisco
Baños-Hernández, Christian Johana
Parra-Rojas, Isela
Montoya-Buelna, Margarita
Sánchez-Hernández, Pedro Ernesto
KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico
title KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico
title_full KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico
title_fullStr KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico
title_full_unstemmed KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico
title_short KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico
title_sort kir/hla gene profile implication in systemic sclerosis patients from mexico
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339729/
https://www.ncbi.nlm.nih.gov/pubmed/30723749
http://dx.doi.org/10.1155/2019/6808061
work_keys_str_mv AT machadosulbaranandreacarolina kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico
AT ramirezduenasmariaguadalupe kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico
AT navarrozarzajoseeduardo kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico
AT munozvallejosefrancisco kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico
AT mendozacarrerafrancisco kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico
AT banoshernandezchristianjohana kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico
AT parrarojasisela kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico
AT montoyabuelnamargarita kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico
AT sanchezhernandezpedroernesto kirhlageneprofileimplicationinsystemicsclerosispatientsfrommexico